Riskpilot← Back to searchSign inGet full accessAnsiktskirurgi i Värmland AB
ABActiveOrg 5568615925Södra Sanna 526Medical specialists activities · NACE 8622Est. 20110 employees
Revenue 2025
SEK 1,3M
+3% vs 2024
EBITDA margin
46.6%
+12% vs 2024
Equity ratio
76.7%
Financial strength
Net profit 2025
SEK 428K
+18% vs 2024
| Revenue | SEK 1,3M | +3% |
| EBITDA | SEK 583K | +12% |
| Net profit | SEK 428K | +18% |
| Total assets | SEK 827K | +9% |
| Equity | SEK 634K | +8% |
| Employees | 0 | — |
Legal name
Ansiktskirurgi i Värmland AB
Org number
5568615925
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 augusti 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukvård, medicinska behandlingar, konsultationer inom Öron-näsa-hals-specialiteten och kirurgi inom huvud-halsområdet samt därutöver, därmed förenlig verksamhet. Bolaget skall även genomföra utbildningar, föreläsningar samt bedriva därmed förenlig verksamhet. Därtill skall bolaget bedriva boxningsläkarverksamhet och genomföra medicinska bedömningar inför och under tävlingar inom boxning.
Address
Södra Sanna 526
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 060 | 1 099 | 943 | 1 209 | 1 250 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 415 | 431 | 352 | 521 | 583 |
| Depreciation & amort. | −0 | −0 | −23 | −45 | −45 |
| EBIT | 415 | 431 | 329 | 476 | 538 |
| Net financials | — | — | 1 | 4 | 2 |
| Profit before tax | 414 | 431 | 330 | 459 | 540 |
| Tax | −86 | −89 | −69 | −97 | −112 |
| Net profit | 328 | 342 | 261 | 362 | 428 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 616 | 627 | 635 | 760 | 827 |
| Equity | 411 | 433 | 474 | 586 | 634 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 205 | 194 | 161 | 152 | 171 |
| Total debt | 205 | 194 | 161 | 152 | 171 |
EBITDA margin
46.6%
This company
15.8%
Market median
+195% vs market
20212025
Equity ratio
76.7%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
67.5%
This company
18.4%
Market median
+267% vs market
20212025
Net profit margin
34.2%
This company
8.1%
Market median
+322% vs market
20212025
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ansiktskirurgi i Värmland AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Sofia Margareta Sjögren | Board of Directors | 0 companies |
| Magnus Christian K-G Strandqvist | Deputy Board Member | 0 companies |